Novostella,10 mg, tablets
Prasterone
This medicine should always be taken exactly as described in this patient leaflet or as directed by your doctor or pharmacist.
Novostella contains the active substance prasterone (dehydroepiandrosterone, DHEA), which belongs to the group of steroid hormones. Its amount in the body decreases with age. The highest concentration of prasterone in women occurs between 20 and 30 years of age, and after 30 years, it decreases gradually.
Novostella is indicated for the treatment of dehydroepiandrosterone (prasterone) deficiency in women with laboratory-confirmed prasterone deficiency.
Supporting effects of prasterone have been demonstrated in the following cases:
Before starting to take Novostella, you should discuss it with your doctor, who will order the necessary tests and decide on the need to use this medicine based on their results.
Women under 40 should not take this medicine.
If severe side effects occur, you should stop taking the medicine and contact your doctor.
Without consulting your doctor, you should not change or increase the dose of the medicine.
Taking higher doses than recommended for a longer period may cause:
Treatment of menopausal symptoms in older women should be started after careful analysis of the benefits and potential risks associated with the use of the medicine, together with your doctor.
In the case of long-term use of the medicine in doses higher than 2 tablets (20 mg) per day, prasterone levels in the blood should be monitored, and medical examinations should be performed at regular intervals.
Novostella should not be used by athletes, as it belongs to the group of prohibited anabolic-androgenic agents.
Novostella should not be taken by women using hormone replacement therapy (HRT).
If side effects such as acne or skin oiliness occur, you should stop taking the medicine for 2-3 weeks. After this time, you can continue treatment using a lower dose than before, but it is recommended to consult a doctor. If side effects occur again, you should not take the medicine.
Novostella should not be used in children and adolescents.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
You should inform your doctor if you are taking any of the following medicines:
If you are not sure whether you are taking any of the above medicines, you should ask your doctor.
The medicine should be taken during a meal to facilitate absorption.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, you should consult your doctor or pharmacist before taking this medicine.
Novostella is contraindicated in women during pregnancy and breastfeeding.
If a woman taking Novostella becomes pregnant, she should stop taking the medicine immediately and contact her doctor as soon as possible.
There is no data on the effect of the medicine on the ability to drive and use machines.
If you have been diagnosed with an intolerance to some sugars, you should contact your doctor before taking the medicine.
This medicine should always be taken exactly as described in this patient leaflet or as directed by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
The initial dose is 1 tablet (10 mg) once a day.
The medicine should be taken in the morning, in accordance with the natural rhythm of DHEA hormone secretion.
The initial dose should be gradually increased (by 1 tablet per day after 2 weeks) until the desired therapeutic effects are achieved. The smallest effective dose is recommended.
Dose changes, especially increases, always require consultation with a doctor.
A maximum of 2 tablets (20 mg) can be taken per day.
In the case of long-term use of doses higher than 2 tablets (20 mg) in women (only with a doctor's prescription), prasterone levels in the blood should be monitored at regular intervals, as ordered by the doctor.
Elderly patients usually require higher doses of the medicine due to decreased DHEA production. The use of higher doses should be consulted with a doctor.
Novostella should not be used in children and adolescents.
The medicine should be taken orally.
The medicine should be taken during a meal to facilitate absorption.
Dosing should be adjusted according to prasterone levels in the blood and the effectiveness of therapy.
Novostella is intended for long-term use; the effects of the medicine become visible after several weeks of use.
In case of taking a higher dose of the medicine than recommended, you should contact your doctor.
You should continue taking the medicine without increasing the next dose.
You should not take a double dose to make up for a missed dose.
If you have any further doubts about the use of this medicine, you should consult your doctor or pharmacist.
Like all medicines, Novostella can cause side effects, although not everybody gets them.
If you experience any of the following symptoms, you should stop taking the medicine and contact your doctor.
Rare(occurring in 1 to 10 patients out of 10,000):
Very rare(occurring in less than 1 patient out of 10,000):
The medicine is generally well-tolerated when used in recommended doses.
The likelihood of side effects may increase when the medicine is used in higher doses than recommended and for a longer period.
If you experience any side effects, including those not listed in this leaflet, you should contact your doctor or pharmacist.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton. The expiry date refers to the last day of the month.
Store in a temperature below 25°C.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The medicine is in the form of tablets.
The tablets are packaged in blisters and cardboard boxes. Each box contains 30 or 60 tablets.
Aflofarm Farmacja Polska Sp. z o.o.
ul. Partyzancka 133/151
95-200 Pabianice
Phone: (42) 22-53-100
Aflofarm Farmacja Polska Sp. z o.o.
ul. Szkolna 31
95-054 Ksawerów
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.